Nonsteroidal Anti‐Inflammatory Drugs and the Risk of Periodontitis Among Adults With Osteoarthritis: A Target Trial Emulation
Ignacio Leiva‐Escobar, Aiswarya Puzhakkara Chennas, Zoheir Alayash, Stefan Lars Reckelkamm, Birte Holtfreter, Thomas Kocher, Sebastian‐Edgar Baumeister, Michael Nolde · 2026
Read Nonsteroidal Anti‐Inflammatory Drugs and the Risk of Periodontitis Among Adults With Osteoarthritis: A Target Trial Emulation by Ignacio Leiva‐Escobar, Aiswarya Puzhakkara Chennas, Zoheir Alayash, Stefan Lars Reckelkamm, Birte Holtfreter, Thomas Kocher, Sebastian‐Edgar Baumeister, Michael Nolde (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13371416.txt.
Description
Ignacio Leiva-Escobar and colleagues test whether anti-inflammatory painkillers protect against gum disease in adults with osteoarthritis in a 2026 study. NSAIDs block cyclooxygenase enzymes and might slow gum tissue breakdown, but long-term effects were unknown. Using United States health records from 1995 to 2019, the team emulated trials comparing new NSAID users with new acetaminophen users.
Over five years, the risk difference for new periodontitis was only 0.13 percentage points, with a range spanning zero. Results were similar for non-selective and preferential COX-2 drugs, and a negative control outcome, dental caries, also showed no clear difference. The study finds no evidence that starting NSAIDs, rather than acetaminophen, changes gum disease risk in this group.
Catalog record
| CREATOR | Ignacio Leiva‐Escobar, Aiswarya Puzhakkara Chennas, Zoheir Alayash, Stefan Lars Reckelkamm, Birte Holtfreter, Thomas Kocher, Sebastian‐Edgar Baumeister, Michael Nolde |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |